新型冠状病毒肺炎疫苗接种后的心肌炎和心包炎
Myocarditis and pericarditis after vaccination for COVID-19.
作者信息
Hudson Blake, Mantooth Ryan, DeLaney Matthew
机构信息
University of Alabama at Birmingham Mantooth is Washington Regional Medical Center Birmingham Alabama USA.
Washington Regional Medical Center Fayetteville Arkansas USA.
出版信息
J Am Coll Emerg Physicians Open. 2021 Jul 26;2(4):e12498. doi: 10.1002/emp2.12498. eCollection 2021 Aug.
Abstract
Two previously healthy males presented to the emergency symptoms with signs of pericarditis/myocarditis after being vaccinated with an mRNA vaccine for COVID-19.
摘要
两名此前健康的男性在接种新冠mRNA疫苗后，出现了心包炎/心肌炎的症状和体征，并前往急诊就诊。
相似文献
1
Myocarditis and pericarditis after vaccination for COVID-19.
J Am Coll Emerg Physicians Open. 2021 Jul 26;2(4):e12498. doi: 10.1002/emp2.12498. eCollection 2021 Aug.
2
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
PLoS Med. 2022 Jul 28;19(7):e1004056. doi: 10.1371/journal.pmed.1004056. eCollection 2022 Jul.
3
Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination-A nationwide study.
J Microbiol Immunol Infect. 2023 Jun;56(3):558-565. doi: 10.1016/j.jmii.2023.01.016. Epub 2023 Feb 8.
4
Myocarditis or Pericarditis Following the COVID-19 Vaccination in Adolescents: A Systematic Review.
Vaccines (Basel). 2022 Aug 15;10(8):1316. doi: 10.3390/vaccines10081316.
5
Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.
Vaccine. 2022 Jul 30;40(32):4663-4671. doi: 10.1016/j.vaccine.2022.05.048. Epub 2022 May 25.
6
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination.
Vaccine. 2022 Aug 19;40(35):5153-5159. doi: 10.1016/j.vaccine.2022.07.007. Epub 2022 Jul 12.
7
Management of cardiovascular symptoms after Pfizer-BioNTech COVID-19 vaccine in teenagers in the emergency department.
J Formos Med Assoc. 2023 Aug;122(8):699-706. doi: 10.1016/j.jfma.2022.12.004. Epub 2022 Dec 13.
8
Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system.
Front Immunol. 2022 Sep 12;13:938322. doi: 10.3389/fimmu.2022.938322. eCollection 2022.
9
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand.
Vaccines (Basel). 2023 Mar 28;11(4):749. doi: 10.3390/vaccines11040749.
10
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445.
引用本文的文献
1
CMR Manifestations, Influencing Factors and Molecular Mechanism of Myocarditis Induced by COVID-19 Mrna Vaccine.
Rev Cardiovasc Med. 2022 Oct 11;23(10):339. doi: 10.31083/j.rcm2310339. eCollection 2022 Oct.
2
CMR findings after COVID-19 and after COVID-19-vaccination-same but different?
Int J Cardiovasc Imaging. 2022 Sep;38(9):2057-2071. doi: 10.1007/s10554-022-02623-x. Epub 2022 May 12.
3
Myocarditis Following COVID-19 Vaccination: A Systematic Review.
Cureus. 2023 Apr 22;15(4):e37999. doi: 10.7759/cureus.37999. eCollection 2023 Apr.
4
Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases.
Biomol Biomed. 2023 Jul 3;23(4):546-567. doi: 10.17305/bb.2022.8779.
5
Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review.
Medicines (Basel). 2022 Aug 11;9(8):43. doi: 10.3390/medicines9080043.
6
Giant cell myocarditis following COVID-19 successfully treated by immunosuppressive therapy.
Clin Case Rep. 2022 Aug 9;10(8):e6196. doi: 10.1002/ccr3.6196. eCollection 2022 Aug.
7
Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis-A systematic review.
Rechtsmedizin (Berl). 2023;33(2):125-131. doi: 10.1007/s00194-022-00587-9. Epub 2022 Jul 20.
8
Unraveling the Mystery of COVID-19 Postvaccination Myocarditis: A Systematic Review of Current Cases.
Int J Clin Pract. 2022 Jan 31;2022:2438913. doi: 10.1155/2022/2438913. eCollection 2022.
9
Myocarditis after COVID-19 mRNA vaccination: A systematic review of case reports and case series.
Clin Cardiol. 2022 Jul;45(7):691-700. doi: 10.1002/clc.23828. Epub 2022 Jun 2.
10
Development of myocarditis and pericarditis after COVID-19 vaccination in adult population: A systematic review.
Ann Med Surg (Lond). 2022 Apr;76:103486. doi: 10.1016/j.amsu.2022.103486. Epub 2022 Mar 11.
本文引用的文献
1
Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association.
Circulation. 2020 Feb 11;141(6):e69-e92. doi: 10.1161/CIR.0000000000000745. Epub 2020 Jan 6.
2
Diagnostic and prognostic role of electrocardiogram in acute myocarditis: A comprehensive review.
Ann Noninvasive Electrocardiol. 2020 May;25(3). doi: 10.1111/anec.12726. Epub 2019 Nov 28.
3
Acute Fulminant Myocarditis Following Influenza Vaccination Requiring Extracorporeal Membrane Oxygenation.
Acute Crit Care. 2019 May;34(2):165-169. doi: 10.4266/acc.2017.00045. Epub 2018 Nov 7.
4
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System.
Int J Cardiol. 2018 Dec 15;273:183-186. doi: 10.1016/j.ijcard.2018.09.054. Epub 2018 Sep 14.
5
Myocarditis and pericarditis are rare following live viral vaccinations in adults.
Vaccine. 2018 Mar 14;36(12):1524-1527. doi: 10.1016/j.vaccine.2018.02.030. Epub 2018 Feb 15.
6
A prospective study of the incidence of myocarditis/pericarditis and new onset cardiac symptoms following smallpox and influenza vaccination.
PLoS One. 2015 Mar 20;10(3):e0118283. doi: 10.1371/journal.pone.0118283. eCollection 2015.
Zotero 插件